{
    "title": "Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults",
    "pmid": "20338069",
    "pmcid": "PMC2859392",
    "study_parameters": [
        {
            "Study Parameters ID": 1448993668,
            "Variant Annotation ID": 1448993666,
            "Study Type": "cohort",
            "Study Cases": 65.0,
            "Study Controls": null,
            "Characteristics": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.62,
            "Allele Of Frequency In Cases": "G",
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "> 0.05",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1448993666"
        },
        {
            "Study Parameters ID": 1184988079,
            "Variant Annotation ID": 1184988061,
            "Study Type": "cohort",
            "Study Cases": 65.0,
            "Study Controls": null,
            "Characteristics": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
            "Characteristics Type": "Study Cohort",
            "Frequency In Cases": 0.62,
            "Allele Of Frequency In Cases": "G",
            "Frequency In Controls": null,
            "Allele Of Frequency In Controls": null,
            "P Value": "< 0.0001",
            "Ratio Stat Type": "OR",
            "Ratio Stat": null,
            "Confidence Interval Start": null,
            "Confidence Interval Stop": null,
            "Biogeographical Groups": "East Asian",
            "Variant Annotation ID_norm": "1184988061"
        }
    ],
    "var_drug_ann": [
        {
            "Variant Annotation ID": 1448993666,
            "Variant/Haplotypes": "rs3745274",
            "Gene": "CYP2B6",
            "Drug(s)": "efavirenz",
            "PMID": 20338069,
            "Phenotype Category": "Efficacy",
            "Significance": "no",
            "Notes": "No significant difference in median CD4 T cell counts of each genotype at different time points was seen in efavirenz group (p = 0.818, 0.838, 0.783, 0.753 and 0.587 for baseline, weeks 12, 24, 36 and 48 of ART, respectively).",
            "Sentence": "Genotype TT is not associated with response to efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Not associated with",
            "Direction of effect": null,
            "PD/PK terms": "response to",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease, Disease:Tuberculosis",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "GG + GT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "20338069",
            "Variant Annotation ID_norm": "1448993666"
        },
        {
            "Variant Annotation ID": 1184988061,
            "Variant/Haplotypes": "rs3745274",
            "Gene": "CYP2B6",
            "Drug(s)": "efavirenz",
            "PMID": 20338069,
            "Phenotype Category": "Metabolism/PK",
            "Significance": "yes",
            "Notes": "Association with significantly increased efavirenz plasma levels. Was significant at week 6, 12 of treatment and 1 month after rifampicin discontinuation.",
            "Sentence": "Genotype TT is associated with decreased metabolism of efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.",
            "Alleles": "TT",
            "Specialty Population": null,
            "Metabolizer types": null,
            "isPlural": "Is",
            "Is/Is Not associated": "Associated with",
            "Direction of effect": "decreased",
            "PD/PK terms": "metabolism of",
            "Multiple drugs And/or": null,
            "Population types": "in people with",
            "Population Phenotypes or diseases": "Disease:HIV infectious disease, Disease:Tuberculosis",
            "Multiple phenotypes or diseases And/or": "and",
            "Comparison Allele(s) or Genotype(s)": "GG + GT",
            "Comparison Metabolizer types": null,
            "PMID_norm": "20338069",
            "Variant Annotation ID_norm": "1184988061"
        }
    ],
    "var_pheno_ann": [],
    "var_fa_ann": []
}